Indoco Remedies will hold a meeting of the Board of Directors of the Company on 24 July 2025.Powered by Capital Market - Live News

 Indoco Remedies announced final approval of Allopurinol Tablets USP, 200 mg through Company`s Abbreviated New Drug Application (ANDA) for Allopurinol Tablets USP to market a generic equivalent to the reference listed drug (RLD), ZYLOPRIM 200 mg of Casper Pharma LLC from USFDA.Powered by Capital Market - Live News

Net loss of Indoco Remedies reported to Rs 40.39 crore in the quarter ended March 2025 as against net profit of Rs 22.70 crore during the previous quarter ended March 2024. Sales declined 12.57% to Rs 383.89 crore in the quarter ended March 2025 as against Rs 439.08 crore during the previous quarter ended March 2024.For the full year,net loss reported to Rs 73.74 crore in the year ended March 2025 as against net profit of Rs 98.47 crore during the previous year ended March 2024. Sales declined 8.22% to Rs 1641.29 crore in the year ended March 2025 as against Rs 1788.22 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales383.89439.08 -13 1641.291788.22 -8 OPM %-0.2011.13 -6.0513.66 - PBDT-16.7439.48 PL 38.48216.14 -82 PBT-45.5213.25 PL -75.36124.27 PL NP-40.3922.70 PL -73.7498.47 PL Powered by Capital Market - Live News

Net loss of Indoco Remedies reported to Rs 26.24 crore in the quarter ended March 2025 as against net profit of Rs 37.56 crore during the previous quarter ended March 2024. Sales declined 21.62% to Rs 341.07 crore in the quarter ended March 2025 as against Rs 435.14 crore during the previous quarter ended March 2024.For the full year,net loss reported to Rs 8.73 crore in the year ended March 2025 as against net profit of Rs 116.64 crore during the previous year ended March 2024. Sales declined 15.16% to Rs 1494.78 crore in the year ended March 2025 as against Rs 1761.95 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales341.07435.14 -22 1494.781761.95 -15 OPM %1.0113.18 -8.5714.64 - PBDT-6.0250.50 PL 89.89229.67 -61 PBT-30.9026.77 PL -8.36141.69 PL NP-26.2437.56 PL -8.73116.64 PL Powered by Capital Market - Live News

Indoco Remedies will hold a meeting of the Board of Directors of the Company on 22 May 2025.Powered by Capital Market - Live News